BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 2004
View Archived Issues
Opioid growth factor phase I trial in patients with advanced inoperable pancreatic carcinoma
Read More
Talaporfin reported to reduce choroidal leakage in ARMD
Read More
Biocryst reports exciting progress during past quarter
Read More
Avant Immunotherapeutics achieves notable milestones in the first quarter
Read More
Novel human anticancer vaccine elicits cellular responses
Read More
Insight into mechanism of action of AGI-1067
Read More
Laquinimod reported to delay progression of multiple sclerosis
Read More
Clinical benefits of pramlintide in the treatment of diabetes
Read More
Rasagiline improves motor fluctuations and freezing of gait in advanced PD
Read More
Promising results reported for AdPEDF.11 in choroidal neovascularization
Read More
Prous Science's LifeSci Channel posts several new exiting programs
Read More
Five series of ALK5 kinase inhibitors presented by Pfizer
Read More
AstraZeneca claims 11beta-HSD1 inhibitors for diabetes, obesity, etc.
Read More
Cyclic peptide with glucagon antagonist activity isolated from Streptomyces cultures
Read More
New cannabinoid CB1 antagonists/inverse agonists claimed by Pfizer
Read More
Pfizer patent covers p38 MAP kinase inhibitors and their therapeutic use
Read More
French researchers describe imidazoline-based glucose and lipid lowering agents
Read More
First portion of Entereg NDA submitted
Read More
Biovitrum and Symphogen enter recombinant polyclonal antibody collaboration
Read More
Visudyne launched in Japan
Read More
ARIC data support stroke predictive value of Lp-PLA2
Read More
CTA submitted for Canadian phase I trials of TAFA-93
Read More
New phase II trial for Aplidin in SCLC
Read More
Sysmex collaboration to test automated cervical cancer screening technology
Read More
Exanta completes E.U. mutual recognition procedure
Read More
SPA for phase III GVAX prostate cancer vaccine trial
Read More
IDEA-070 reduces cutaneous inflammation
Read More
HE-2000 reduces HIV load, opportunistic infections in AIDS patients
Read More
Tolevamer development advances based on study results
Read More
Recent results with tamsulosin reported at AUA annual meeting
Read More
Study shows melatonin improves nocturia
Read More
Peptimmune licenses rights to GT389-255 from Genzyme
Read More